COSOPT PF Drug Patent Profile
✉ Email this page to a colleague
When do Cosopt Pf patents expire, and when can generic versions of Cosopt Pf launch?
Cosopt Pf is a drug marketed by Thea Pharma and is included in one NDA.
The generic ingredient in COSOPT PF is dorzolamide hydrochloride; timolol maleate. There are fifteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride; timolol maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cosopt Pf
A generic version of COSOPT PF was approved as dorzolamide hydrochloride; timolol maleate by HIKMA on October 28th, 2008.
Summary for COSOPT PF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Clinical Trials: | 35 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in COSOPT PF? | COSOPT PF excipients list |
| DailyMed Link: | COSOPT PF at DailyMed |
Recent Clinical Trials for COSOPT PF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Wills Eye | Phase 2/Phase 3 |
| Mid Atlantic Retina | Phase 2/Phase 3 |
| Wills Eye | Phase 2 |
Pharmacology for COSOPT PF
| Drug Class | Carbonic Anhydrase Inhibitor beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists Carbonic Anhydrase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for COSOPT PF
US Patents and Regulatory Information for COSOPT PF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thea Pharma | COSOPT PF | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 202667-001 | Feb 1, 2012 | AT2 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
